title: Potential application of non-flavonoid phenolics in diabetes: antiinflammatory effects.
abstract: Polyphenols are members of a very large family of plant-derived compounds that may have beneficial effects on human health, and thus their study has become an increasingly important area of human nutrition research. Considering that it is increasingly accepted that chronic sub-acute inflammation plays an important role in the development of insulin resistance and of diabetes in animals and in humans, the aim of the present review is to compile information concerning the anti-inflammatory effects of non-flavonoid polyphenols on diabetes prevention and/or treatment. Most of these studies have been carried out with different cultured cells and using animal models displaying different types of diabetes, such as diabetes induced by streptozotocin or streptozotocin-nicotinamide, genetic diabetes or diabetes induced by high-fat feeding. In general terms, non-flavonoid polyphenols reduce the production of inflammatory mediators, such as IL-1β, IL-8, MCP-1, COX-2 or iNOS in these animal models of diabetes. This effect is accompanied in the vast majority of these studies by improved insulin action. In addition, some of the non-flavonoid polyphenols are also able to ameliorate or prevent several pathological alterations associated with the development of diabetes, such as nephropathy, cardiopathy or retinopathy. Very little information has been reported with regard to human studies to date. Thus, new studies are needed to confirm if the beneficial effects observed in preclinical studies can apply to human beings.
authors.forename: J
authors.initials: J
authors.lastname: Miranda
authors.forename: A
authors.initials: A
authors.lastname: Lasa
authors.forename: L
authors.initials: L
authors.lastname: Aguirre
authors.forename: A
authors.initials: A
authors.lastname: Fernandez-Quintela
authors.forename: I
authors.initials: I
authors.lastname: Milton
authors.affiliation: Dpt. Nutrición y Bromatología, Facultad de Farmacia, Paseo de la Universidad, 7, 01006 Vitoria, Espana. mariapuy.portillo@ehu.es.
authors.forename: M P
authors.initials: MP
authors.lastname: Portillo
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003474:Curcumin / Q000627:therapeutic use; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004195:Disease Models, Animal; D006801:Humans; D062385:Hydroxybenzoates / Q000627:therapeutic use; D010636:Phenols / Q000627:therapeutic use*; D053284:Polyunsaturated Alkamides / Q000627:therapeutic use; D013267:Stilbenes / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D062385:Hydroxybenzoates; D010636:Phenols; D053284:Polyunsaturated Alkamides; D013267:Stilbenes; D003474:Curcumin